default author photo

Patrick Lenehan

nference, Inc.

One Main Street

East Arcade

Cambridge, MA 02142

United States

SCHOLARLY PAPERS

7

DOWNLOADS

1,451

TOTAL CITATIONS

17

Scholarly Papers (7)

Actions:
Email selected abstracts
1.

Real-World Effectiveness of Ad26.COV2.S Adenoviral Vector Vaccine for COVID-19

Number of pages: 18 Posted: 10 May 2021
Juan Corchado-Garcia, David Puyraimond-Zemmour‬, Travis Hughes, Tudor Cristea-Platon, Patrick Lenehan, Colin Pawlowski, Sairam Bade, John C. O'Horo, Gregory J. Gores, Amy W. Williams, Andrew D. Badley, John Halamka, Abhinash Virk, Melanie D. Swift, Tyler Wagner and Venky Soundararajan
nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference Labs, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, nference, Inc. and nference, Inc.
Downloads 966 (59,401)
Citation 3

Abstract:

Loading...

2.

Genomic Diversification of Long Polynucleotide Fragments Is a Signature of Emerging SARS-CoV-2 Variants of Concern

Number of pages: 22 Posted: 11 Jan 2022
Karthik Murugadoss, Michiel Neisen, Bharathwaj Raghunathan, Patrick Lenehan, Pritha Ghosh, Tyler Feener, Praveen Anand, Safak Simsek, Rohit Suratekar, Travis Hughes and Venky Soundararajan
nference, nference, nference, nference, Inc., nference, nference, nference, nference, nference, Inc., nference, Inc. and nference, Inc.
Downloads 141 (524,371)

Abstract:

Loading...

COVID-19, SARS-CoV-2, variant, variants, variant of concern, variants of concern, omicron variant, omicron, delta variant, delta, viral evolution, fitter strains

3.

Casirivimab-Imdevimab Treatment Is Associated with Reduced Rates of Hospitalization Among High-Risk Patients with Mild to Moderate Coronavirus Disease-19

Number of pages: 25 Posted: 01 Jun 2021
Raymund R. Razonable, Colin Pawlowski, John C. O'Horo, Lori L. Arndt, Richard Arndt, Dennis M. Bierle, Molly Destro Borgen, Sara N. Hanson, Michelle C. Hedin, Patrick Lenehan, Arjun Puranik, Leigh L. Speicher, Maria Seville, Sidna M. Tulledge-Scheitel, AJ Venkatakrishnan, Caroline G. Wilker, Andrew D. Badley and Ravindra Ganesh
Mayo Clinic, nference, Inc., Mayo Clinic, Mayo Clinic, Independent, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, nference, Inc., nference, Inc., Mayo Clinic, Mayo Clinic, Mayo Clinic - College of Medicine and Science, nference, Inc., Mayo Clinic, Mayo Clinic and Mayo Clinic
Downloads 135 (540,814)
Citation 4

Abstract:

Loading...

4.

Female-Male Differences in COVID Vaccine Adverse Events Have Precedence in Seasonal Flu Shots: A Potential Link to Sex-Associated Baseline Gene Expression Patterns

Number of pages: 18 Posted: 13 Apr 2021
AJ Venkatakrishnan, Praveen Kumar-M, Eli Silvert, Enrique Garcia-Rivera, Mariola Szenk, Rohit Suratekar, Patrick Lenehan, Emily Lindemer, John C. O'Horo, Amy W. Williams, Andrew D. Badley, Abhinash Virk, Melanie D. Swift, Gregory J. Gores and Venky Soundararajan
nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic and nference, Inc.
Downloads 98 (699,467)

Abstract:

Loading...

5.

Comparison of COVID-19 with Other Leading Causes of Death in the United States

Number of pages: 16 Posted: 30 Apr 2021
Arjun Puranik, Michiel JM Niesen, Emily Lindemer, Patrick Lenehan, Tudor Cristea-Platon, Colin Pawlowski and Venky Soundararajan
nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc. and nference, Inc.
Downloads 54 (1,020,567)

Abstract:

Loading...

6.

Comparison of Two Highly-Effective mRNA Vaccines for COVID-19 During Periods of Alpha and Delta Variant Prevalence

Number of pages: 29 Posted: 10 Aug 2021
Arjun Puranik, Patrick Lenehan, Eli Silvert, Michiel JM Niesen, Juan Corchado-Garcia, John C. O'Horo, Abhinash Virk, Melanie D. Swift, John Halamka, Andrew D. Badley, AJ Venkatakrishnan and Venky Soundararajan
nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, nference, Inc. and nference, Inc.
Downloads 32 (1,290,922)
Citation 10

Abstract:

Loading...

7.

Severe Acute Infection and Chronic Pulmonary Disease are Risk Factors for Developing Post-COVID-19 Conditions

Number of pages: 35 Posted: 09 Feb 2023
Pritha Ghosh, Michiel JM Niesen, Colin Pawlowski, Hari Bandi, Unice Yoo, Patrick Lenehan, Praveen Kumar-M, Mihika Nadig, Jason Ross, Sankar Ardhanari, John C. O'Horo, AJ Venkatakrishnan, Clifford J. Rosen, Amalio Telenti, Ryan T. Hurt and Venky Soundararajan
nference, nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., Mayo Clinic, nference, Inc., MaineHealth - Maine Medical Center, VIR Biotechnology Inc, Mayo Clinic and nference, Inc.
Downloads 25 (1,385,945)

Abstract:

Loading...

COVID-19, post-acute sequelae of COVID-19, observational study